1. THE ROLE OF TREATMENT LITERACY AND PLHIV EMPOWERMENT Lihle Dlamini (Treatment Action Campaign, South Africa):

2. Introduction  Civil society organisation  10 December 1998  SA based in 7/9 provinces with over 53 Accredited branches (Support groups)  Programmes-PTL, CHA and PCR

3. How we do Treatment Literacy  Taking science into communities and support groups  HIV lifecycle  ART regimens, benefits and side effects  Preventions  Community education  Drug laws  Trips and patents  Drug pricing- generics  Fixed dose combinations

4. Treatment Literacy training workshops

5. Communitymobilisation

6. PLHIV Demanding access  Closer health care facilities  Access to ART e.g. PMTCT/ Rx plan  Policy engagement – SANAC  Rx for Ois e.gFluconazole- Amphotericin B  Reproductive health rights  HPTN 052 study results  Early treatment  Importance of adherene

7. Challenging Pharmaceutical companies

8. Demonstrations towards government

9. Fighting denialism

10. The Results- 2 years on…

11. Using media to spread the word…

12. Taking ART  Adherence  Prolonged lives  Healthy lifestyles- “back to work”  Knowing PLHIV rights

13. More to do…  Form adherence clubs  Advocate for better Rx regimens  TB/HIV integration  Early treatment  Combating stigma  Supporting recently diagnosed people  Role in prevention

14. The Results- 2010/11